发明公开
- 专利标题： TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR
-
申请号： US17449679申请日： 2021-10-01
-
公开(公告)号： US20240299489A9公开(公告)日： 2024-09-12
- 发明人: Michael Heartlein , Frank DeRosa , Alan Kimura , Jonathan Abysalh , Anusha Dias , Shrirang Karve , Zarna Patel
- 申请人： Translate Bio, Inc.
- 申请人地址： US MA Lexington
- 专利权人： Translate Bio, Inc.
- 当前专利权人： Translate Bio, Inc.
- 当前专利权人地址： US MA Lexington
- 分案原申请号： US15981757 2018.05.16
- 主分类号： A61K38/17
- IPC分类号： A61K38/17 ; A61K9/00 ; A61K9/127 ; A61K48/00 ; A61P11/12
摘要：
The present invention provides, among other things, methods of treating cystic fibrosis, comprising a step of administering to a subject in need of treatment a composition comprising an mRNA encoding a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, wherein the mRNA encoding the CFTR protein comprises a polynucleotide sequence at least 80% identical to SEQ ID NO: 1, wherein the mRNA is at a concentration of at least 0.4 mg/mL, and wherein the step of administering comprises inhalation.
公开/授权文献
信息查询
IPC分类:
